IP Library Granted Patent US 7,736,847
Granted Patent B2
US 7,736,847 · App. 10/526,706 · Granted Jun 15, 2010

Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics

Assignee: Intervet International B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,736,847
App. No.
10/526,706
Granted
Jun 15, 2010
Kind
B2
Abstract

Embodiments of the present invention generally relate to novel methods for the treatment and/or prevention of neurological symptoms caused by an avian reovirus, enteric reovirus strain (ERS), and associated characteristics. Other embodiments generally comprise an immunogenic composition or vaccine comprising an ERS for the treatment and/or prevention of neurological symptoms.

Claims (5)

1. A method for protecting poultry from neurological symptoms caused by avian reovirus, comprising administering an effective amount of an immunogenic composition comprising an avian reovirus, wherein the avian reovirus is selected from the group consisting of strain ERS 060E (ATCC Deposit number PTA-4782), strain ERS 074 (ATCC Deposit number PTA-4783), and strain ERS 1037 (ATCC Deposit number PTA-4735), and wherein the poultry is selected from the group consisting of chickens, turkeys, water fowl, guineas, quail, pigeons, and ostriches.

2. The method of claim 1 , wherein the reovirus is in a live, attenuated or killed form.

3. The method of claim 1 , wherein the immunogenic composition further comprises a vaccine strain of at least one of Marek's Disease Virus, Infectious Bursal Disease Virus, Newcastle Disease Virus, Infectious Bronchitis Virus, Avian Encephalomyelitis Virus, Fowl Pox Virus, and Chicken Anemia Agent.

4. The method of claim 1 , wherein the immunogenic composition further comprises an adjuvant.

5. The method of claim 1 , wherein the neurological symptoms are selected from the group consisting of tremors and twisted neck.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2006
From: AKZO NOBEL N.V.
To: INTERVET INTERNATIONAL B.V.
Reel/Frame 018490/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2005
From: VAN DE ZANDE, SASKIA; HEIN, RUDOLF GEORGE; SLACUM, GWENLLYAN F.; JENSEN, KAREN L.; LYNCH, PHYLLIS
To: AKZO NOBEL N.V.
Reel/Frame 016188/0887 →
Continuity (5)
Provisional Application 6041724500 · Oct 9, 2002
Provisional Application 6041858600 · Oct 15, 2002
Provisional Application 6042416300 · Nov 6, 2002
Provisional Application 6043519200 · Dec 20, 2002
Related Publication 20080213304A1 · Sep 4, 2008